Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Jun 2024 07:00 AM
RNS
Director/PDMR Shareholding
13 Jun 2024 07:00 AM
RNS
Preliminary Results for the year ended 31 Dec 2023
31 May 2024 07:01 AM
RNS
Notice of Results and Investor Presentation
31 May 2024 07:00 AM
RNS
DeepTech Recycling: Fundraising, Business Update
28 May 2024 07:00 AM
RNS
Investment in Wanda, related party transactions
15 May 2024 02:32 PM
RNS
PDS Biotech: Business Update and Q1 2024 Results
13 May 2024 07:00 AM
RNS
Martlet Capital: mandate and acquisition
10 May 2024 09:12 AM
RNS
PDS Biotech: Clinical trial meets study endpoints
15 Apr 2024 07:00 AM
RNS
ProAxsis secures c.£1.8mn investment
27 Mar 2024 01:34 PM
RNS
PDS Strategy Update and 2023 Financial Results
13 Mar 2024 07:00 AM
RNS
Business Update
05 Feb 2024 07:00 AM
RNS
Exercise of Options and Issue of Shares
23 Jan 2024 07:00 AM
RNS
Glycotest secures $1 million investment
01 Dec 2023 07:00 AM
RNS
DeepTech Recycling secures £1 million investment
14 Nov 2023 04:39 PM
RNS
PDS BioTechnology: Third Quarter Results
13 Nov 2023 07:00 AM
RNS
Director/PDMR Shareholding
09 Nov 2023 05:28 PM
RNS
PDS Biotech Announces Updated Survival Data
06 Nov 2023 07:00 AM
RNS
Ventive secures c.£900,000 investment
02 Nov 2023 07:00 AM
RNS
Change of Adviser
23 Oct 2023 06:22 PM
RNS
PDS Preliminary Biomarker Study Results
13 Oct 2023 07:00 AM
RNS
Exercise of Options
03 Oct 2023 04:12 PM
RNS
Director/PDMR Shareholding
03 Oct 2023 03:21 PM
RNS
PDS: Interim 24-month survival rate of 74% update
03 Oct 2023 07:00 AM
RNS
PDS Biotech: new data on PDS0101
28 Sep 2023 07:00 AM
RNS
Interim Results
13 Sep 2023 07:00 AM
RNS
Q-Bot: £3.5 million investment to drive expansion
14 Aug 2023 05:55 PM
RNS
PDS Biotech: 2nd Quarter Results, Business Update
14 Aug 2023 05:51 PM
RNS
PDS Biotech: Submission of Phase 3 Protocol to FDA
03 Jul 2023 07:00 AM
RNS
Grant of Options, Issue of Shares, Director/PDMR
30 Jun 2023 07:00 AM
RNS
DName-iT Holdings Limited Fundraising
29 Jun 2023 11:04 AM
RNS
Result of AGM & Board Changes
22 Jun 2023 07:00 AM
RNS
Vortex Fundraising
14 Jun 2023 03:31 PM
RNS
PDS Announces Achievement of Efficacy Threshold
07 Jun 2023 07:00 AM
RNS
Director/PDMR Shareholding
06 Jun 2023 07:00 AM
RNS
Notice of AGM
31 May 2023 07:01 AM
RNS
Preliminary Results for the year ended 31 Dec 2022
31 May 2023 07:00 AM
RNS
Board Changes
26 May 2023 09:39 AM
RNS
PDS Biotech Announces Interim Data
24 May 2023 07:00 AM
RNS
Sofant and Inmarsat announce joint development
15 May 2023 03:16 PM
RNS
PDS Business Update and First Quarter Results
02 May 2023 07:00 AM
RNS
Glycotest, Inc. Fundraising
03 Apr 2023 07:00 AM
RNS
Business Update
30 Mar 2023 03:51 PM
RNS
PDS Update
28 Mar 2023 03:50 PM
RNS
PDS Business Update and 2022 Financial Results
28 Feb 2023 07:00 AM
RNS
Related party loan to ProAxsis Limited
27 Feb 2023 03:28 PM
RNS
PDS completes FDA meeting for triple combination
10 Feb 2023 02:05 PM
RNS
Second Price Monitoring Extn
10 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
10 Feb 2023 11:05 AM
RNS
Second Price Monitoring Extn
10 Feb 2023 11:00 AM
RNS
Price Monitoring Extension

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings